Khalid Ahmad Qidwai
Overview
Explore the profile of Khalid Ahmad Qidwai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tewari J, Qidwai K, Tewari A, Kaur S, Tewari V, Maheshwari A
Expert Rev Clin Pharmacol
. 2025 Jan;
18(1-2):51-66.
PMID: 39817343
Introduction: Retatrutide is a novel triple hormone receptor agonist which has shown great promise in tackling obesity in preliminary trials. We did this systematic review and meta-analysis to pool the...
2.
Tewari J, Qidwai K, Roy S, Saxena M, Rana A, Tewari A, et al.
Egypt Heart J
. 2024 Dec;
76(1):162.
PMID: 39725775
Background: Hypertension is a leading cause of premature mortality and morbidity. Recent guidelines advocate for out-of-office blood pressure monitoring, including ambulatory and home BP monitoring, to better identify hypertension phenotypes...
3.
Tewari J, Qidwai K, Roy S, Rana A, Kumar S, Kumar Sonkar S, et al.
J Diabetes Metab Disord
. 2024 Dec;
24(1):7.
PMID: 39697863
Purpose: Type 2 diabetes mellitus and hypertension frequently coexist, increasing the risk of cardiovascular and renal complications. Urinary Albumin Creatinine Ratio (UACR) serves as a crucial predictor of these outcomes....
4.
Tewari J, Qidwai K, Rana A, Tewari A, Tewari V, Maheshwari A
Cureus
. 2024 Sep;
16(8):e66145.
PMID: 39233944
Remogliflozin is a novel SGLT-2 inhibitor used for the management of Type 2 Diabetes Mellitus (T2DM). Since its introduction medical literature is scarce on its quantitative effects. We performed this...